Theralase appoints Cordoba as Therapeutic Division GM

March 21, 2011
Toronto, ON, Canada--Theralase announced that Jorge Córdoba has been appointed as general manager - Therapeutic Division for its therapeutic medical laser products.

Toronto, ON, Canada--Theralase Technologies (TSXV: TLT) announced that effective immediately, Jorge Córdoba has been appointed as general manager - Therapeutic Division for Theralase’s line of proprietary therapeutic medical laser products. Córdoba, reporting to Roger Dumoulin-White, president and CEO, will have general management responsibilities over the sales, marketing, production, clinical services and regulatory affairs departments.

Córdoba has over 16 years of experience in leading numerous high-technology manufacturing companies to success, providing general management expertise in local and international sales, marketing, production, operations and regulatory affairs. His last position was as director of operations for a $17 million aerospace organization turnaround situation, in which Córdoba, through a number of different initiatives, achieved an increase in productivity of over 400% in less than 2 years. Prior to that, Córdoba successfully launched a 250,000 square foot, $40 million facility for manufacturing high precision assemblies for a division of Magna Inc. In an earlier position, he was the sales and marketing manager for a high tech equipment manufacturer, responsible for sales in excess of $10 million annually.

“I am excited to be part of such a world-class medical organization as Theralase. Under the direction of Roger Dumoulin-White, Theralase has systematically developed valuable intellectual property in the medical laser space and in my estimation is now positioned to rapidly execute on its growth strategy,” said Córdoba. “I accepted the position because Theralase has such wonderful upside, attracting a dedicated team of professionals able to take this intellectual property to the next level and dramatically increase its revenue over the next few years. I look forward to following in Roger’s footsteps to dramatically grow the therapeutic division of the Company.”

Córdoba obtained a Master’s of Business from the Ivey School of Business, University of Western Ontario, London, Ontario in 2005, a Master’s of Science in Advanced Manufacturing Technology from the University of Manchester, Manchester, England in 1993 and a Bachelor of Mechanical-Electrical Engineering from the National University, Mexico City, Mexico in 1989.

SOURCE: Theralase; www.theralase.com/press/TLT_Operations_Manager-03-21-2011.pdf

Posted by:Gail OvertonSubscribe now to Laser Focus World magazine; It’s free! Follow us on TwitterFollow OptoIQ on your iPhone. Download the free App here

Sponsored Recommendations

Brain Computer Interface (BCI) electrode manufacturing

Jan. 31, 2025
Learn how an industry-leading Brain Computer Interface Electrode (BCI) manufacturer used precision laser micromachining to produce high-density neural microelectrode arrays.

Electro-Optic Sensor and System Performance Verification with Motion Systems

Jan. 31, 2025
To learn how to use motion control equipment for electro-optic sensor testing, click here to read our whitepaper!

How nanopositioning helped achieve fusion ignition

Jan. 31, 2025
In December 2022, the Lawrence Livermore National Laboratory's National Ignition Facility (NIF) achieved fusion ignition. Learn how Aerotech nanopositioning contributed to this...

Nanometer Scale Industrial Automation for Optical Device Manufacturing

Jan. 31, 2025
In optical device manufacturing, choosing automation technologies at the R&D level that are also suitable for production environments is critical to bringing new devices to market...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!